Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Philip C. Strassburger Insider Profile
4 Followers
Philip C. Strassburger, GC at Ocular Therapeutix, holds 161.49K shares in Ocular Therapeutix (Ticker: OCUL).
Philip C. Strassburger has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Philip C. Strassburger's holdings
Insider Roles
GC
Roles that Philip C. Strassburger holds in companies
Most Profitable Insider Trade
The most profitable trade made by Philip C. Strassburger
Philip C. Strassburger's Trading History
List of latest transactions for each holding click on a transaction to see Philip C. Strassburger's performance on stock
You May Also Like
Philip C. Strassburger insider profile FAQ
What is the percentage of profitable transactions made by Philip C. Strassburger?
The percentage of profitable transactions made by Philip C. Strassburger is ―.
What is the average return per transaction made by Philip C. Strassburger?
The average return per transaction made by Philip C. Strassburger is ―.
What stocks does Philip C. Strassburger hold?
Philip C. Strassburger holds: OCUL stocks.
What was Philip C. Strassburger’s latest transaction?
Philip C. Strassburger latest transaction was an Uninformative Buy of ―.
What was Philip C. Strassburger's most profitable transaction?
Philip C. Strassburger’s most profitable transaction was an Informative Buy of OCUL stock on February 6, 2024. The return on the trade was 22.40%.
What is Philip C. Strassburger's role in Ocular Therapeutix?
Philip C. Strassburger's role in Ocular Therapeutix is GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.